Evidence map›Paper›PMID 35325367›Full record

ArticleAdvances in therapy2022

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine.

A Elif Müderrisoglu, Matthias Oelke, Tim Schneider, Sandra Murgas, Jean J M C H de la Rosette, Martin C Michel

Abstract read
In one paragraph

Article in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A Elif MüderrisogluDepartment of Medical Pharmacology, Istanbul Medipol University, Istanbul, Turkey.
Matthias OelkeDepartment of Urology, St. Antonius-Hospital, Gronau, Germany.
Tim SchneiderClinic for Urology Rhein Ruhr (PUR/R), Mülheim, Germany.
Sandra MurgasAPOGEPHA Arzneimittel GmbH, Dresden, Germany.
Jean J M C H de la RosetteDepartment of Urology, Medipol Mega University Hospital, Istanbul Medipol University, Istanbul, Turkey.
Martin C MichelDepartment of Pharmacology, Johannes Gutenberg University, Langenbeckstr. 1, 55131, Mainz, Germany. marmiche@uni-mainz.de.ORCID http://orcid.org/0000-0003-4161-8467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUnmet expectations are a major cause of perceived treatment failure and discontinuation of treatment. To enable evidence-based counselling of patients on realistic expectations, we determined the chance of patients with overactive bladder becoming free of a given symptom upon treatment with a muscarinic antagonist in a non-interventional setting.

methodsTwo non-interventional studies included 1335 and 745 patients, respectively, who received 30 or 45 mg q.d. propiverine ER for 12 weeks. They were monitored for becoming free of urgency, urinary incontinence, frequency, or nocturia. Analyses were also performed in subgroups defined by basal symptom severity, age, and gender. Categorical data are shown as a percentage of the respective population. Continuous data are expressed as means or as median depending on whether the variability was considered to exhibit a normal distribution.

resultsThe probability of becoming symptom-free was largest for incontinence and frequency (about 50%), but lesser for urgency (about 20%) and nocturia (about 10%). Greater basal severity of a symptom reduced the chance to become free of that symptom upon treatment, but the chance to become free of incontinence and frequency was still considerable. Age and gender had only minor if any effects on the chance of becoming symptom-free. These findings are in line with those of a limited number of randomized controlled trials.

conclusionThese data provide an evidence base for the counselling of patients with overactive bladder on realistic expectations of treatment outcomes. We propose that realistic expectations can lead to greater long-term adherence.

Indexed as

NocturiaUrinary Bladder, OveractiveUrinary IncontinenceBenzilatesHumansMotivationTreatment OutcomeBenzilatespropiverineOveractive bladder syndromePatient counsellingPropiverineSuccess rateTreatment

Identifiers

PMID35325367
PMCPMC9123021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.